
DrugCard is your trusted partner in local literature screening for the pharmaceutical industry. This cutting-edge AI tool is tailored to streamline drug safety routines, ensuring compliance with regulatory demands while providing transparency and traceability. Key Features and Capabilities: Continuous Screening: Stay up-to-date with the latest local literature in your pharmaceutical markets with regular, automated screening. Transparency: Track and monitor the screening process for accuracy, completeness, and holistic coverage. Scalability: Expand your pharmaceutical operations globally with DrugCard's support for new markets, multiple languages, and suppliers. Cost-Effective: Achieve cost savings by avoiding heavy capital investments, making DrugCard an efficient choice for pharma companies. Global Coverage: Access medical journals from over 35 countries in more than 100 languages, ensuring comprehensive screening. User-Friendly: Tailored for various pharmaceutical users, including Contract Research Organizations (CROs), Marketing Authorization Holders (MAHs), and freelancers. User Benefits: Efficiency: Manage more projects and improve screening results with DrugCard, saving valuable time and resources. Risk Mitigation: Perform in-house screening to mitigate compliance and reputation risks for MAHs. Cost Savings: Freelancers can optimize their time by automating literature screening and focusing on value-added tasks. Global Expansion: Easily expand pharmaceutical operations into new markets with DrugCard's scalability and global coverage. Reliability: Trust in DrugCard's high accuracy rate for scanned PDF screening. Summary: DrugCard is the go-to solution for local literature screening in the pharmaceutical industry. Offering continuous screening, transparency, scalability, and cost-effectiveness, it empowers pharmaceutical companies, CROs, MAHs, and freelancers to streamline drug safety processes, meet regulatory requirements, and ensure compliance with confidence.